Dr. Jubin is a published leader in the field of assay and drug development. His experience includes 5 years as Dir. for R & D at Prolong Pharmaceuticals, 8 years as Dir. of R & D for PBL Interferon Source, a leader in the development of Interferons and Interferon assays & 13 years at Schering-Plough developing anti-viral drugs.

While at PBL, Dr. Jubin worked closely with Sidney Pestka, MD., considered to be the “father of Interferons.”

Mr. Andrews has more than 40 years in financial accounting. He has worked in the life sciences, pharmacy and medical device sectors. His experience includes: CFO of Scripts America, Global Resource Corp. and The Judge Group; Controller of Encapsulation Systems, Goodwin Pumps, Morris Wheeler & Co., and Mater Burt Co.; Audit Manager of Stockton Bates/Gold & Co. and Manager of Ernst & Young Special Services Group.

Mr. Spiegel is a seasoned executive with vast experience in financial markets and fund raising. Afterr graduate school, he joined the management team at UPS, ultimately serving as Mgr. of International Marketing. After leaving UPS, he formed Matrix Communications, a strategic advisory firm proving marketing, strategic planning and economic analysis for companies including Coca-Cola, Sunoco, & the Phila. 76ers.

Robert received a BS in Chemistry from Salisbury U. where his published research on the synthesis of potential Alzheimer’s Disease therapies received multiple grants. He is finishing his PhD in Toxicology at the U. of Maryland Eastern Shore. His dissertation on Herpes Viruses was supported by NIH and featured in over 10 peer reviewed publications. As an entrepreneur and inventor, he has developed tools that enhance research with animals.